| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13fcb85826dff0bcf6af14111d5e48d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7152b10698d14f3506722e7a06cafbfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785ac2b35073f5a6d251678e6fb31b6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e388bf6eccba6baf7f83da6f6b790343 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2002-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ec0e7590dd4336f1f181b56926b84cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed8b7ff8a0bb48ef22c6a87aa158444c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10ce672eed8d6194951842f7bddbaddd |
| publicationDate |
2002-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02079515-A1 |
| titleOfInvention |
Antisense modulation of urokinase plasminogen activator expression |
| abstract |
Antisense compounds, compositions and methods are provided for modulating the expression of urokinase plasminogen activator. The composition comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding urokinase plasminogen activator. Method of using these compounds for modulation of urokinase plasminogen activator expression and for treatment of diseases associated with expression of urokinase plasminogen activator are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115025219-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115025219-B |
| priorityDate |
2001-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |